Indiana 2025 Regular Session

Indiana Senate Bill SB0114 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2	Introduced Version
3	3	SENATE BILL No. 114
4	4	_____
5	5	DIGEST OF INTRODUCED BILL
6	6	Citations Affected: IC 35-48-4.
7	7	Synopsis: Test strips. Removes provisions related to testing the
8	8	strength, effectiveness, or purity of a controlled substance in the
9	9	criminal laws concerning possession of controlled substance
10	10	paraphernalia.
11	11	Effective: July 1, 2025.
12	12	Pol Jr.
13	13	January 8, 2025, read first time and referred to Committee on Corrections and Criminal
14	14	Law.
15	15	2025 IN 114—LS 6555/DI 151 Introduced
16	16	First Regular Session of the 124th General Assembly (2025)
17	17	PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
18	18	Constitution) is being amended, the text of the existing provision will appear in this style type,
19	19	additions will appear in this style type, and deletions will appear in this style type.
20	20	Additions: Whenever a new statutory provision is being enacted (or a new constitutional
21	21	provision adopted), the text of the new provision will appear in this style type. Also, the
22	22	word NEW will appear in that style type in the introductory clause of each SECTION that adds
23	23	a new provision to the Indiana Code or the Indiana Constitution.
24	24	Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
25	25	between statutes enacted by the 2024 Regular Session of the General Assembly.
26	26	SENATE BILL No. 114
27	27	A BILL FOR AN ACT to amend the Indiana Code concerning
28	28	criminal law and procedure.
29	29	Be it enacted by the General Assembly of the State of Indiana:
30	30	1 SECTION 1. IC 35-48-4-8.1, AS AMENDED BY P.L.158-2013,
31	31	2 SECTION 634, IS AMENDED TO READ AS FOLLOWS
32	32	3 [EFFECTIVE JULY 1, 2025]: Sec. 8.1. (a) A person who
33	33	4 manufactures, finances the manufacture of, or designs an instrument,
34	34	5 a device, or other object that is intended to be used primarily for:
35	35	6 (1) introducing into the human body a controlled substance; or
36	36	7 (2) testing the strength, effectiveness, or purity of a controlled
37	37	8 substance; or
38	38	9 (3) (2) enhancing the effect of a controlled substance;
39	39	10 in violation of this chapter commits a Class A infraction for
40	40	11 manufacturing paraphernalia.
41	41	12 (b) A person who:
42	42	13 (1) knowingly or intentionally violates this section; and
43	43	14 (2) has a previous judgment for violation of this section;
44	44	15 commits manufacture of paraphernalia, a Level 6 felony.
45	45	16 SECTION 2. IC 35-48-4-8.3, AS AMENDED BY P.L.187-2015,
46	46	17 SECTION 49, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
47	47	2025 IN 114—LS 6555/DI 151 2
48	48	1 JULY 1, 2025]: Sec. 8.3. (a) This section does not apply to a rolling
49	49	2 paper.
50	50	3 (b) A person who knowingly or intentionally possesses an
51	51	4 instrument, a device, or another object that the person intends to use
52	52	5 for:
53	53	6 (1) introducing into the person's body a controlled substance; or
54	54	7 (2) testing the strength, effectiveness, or purity of a controlled
55	55	8 substance; or
56	56	9 (3) (2) enhancing the effect of a controlled substance;
57	57	10 commits a Class C misdemeanor. However, the offense is a Class A
58	58	11 misdemeanor if the person has a prior unrelated judgment or conviction
59	59	12 under this section.
60	60	13 SECTION 3. IC 35-48-4-8.5, AS AMENDED BY P.L.153-2018,
61	61	14 SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
62	62	15 JULY 1, 2025]: Sec. 8.5. (a) A person who keeps for sale, offers for
63	63	16 sale, delivers, or finances the delivery of a raw material, an instrument,
64	64	17 a device, or other object that is intended to be or that is designed or
65	65	18 marketed to be used primarily for:
66	66	19 (1) ingesting, inhaling, or otherwise introducing into the human
67	67	20 body marijuana, hash oil, hashish, salvia, a synthetic drug, or a
68	68	21 controlled substance;
69	69	22 (2) testing the strength, effectiveness, or purity of marijuana, hash
70	70	23 oil, hashish, salvia, a synthetic drug, or a controlled substance;
71	71	24 (3) (2) enhancing the effect of a controlled substance;
72	72	25 (4) (3) manufacturing, compounding, converting, producing,
73	73	26 processing, or preparing marijuana, hash oil, hashish, salvia, a
74	74	27 synthetic drug, or a controlled substance;
75	75	28 (5) (4) diluting or adulterating marijuana, hash oil, hashish, salvia,
76	76	29 a synthetic drug, or a controlled substance by individuals; or
77	77	30 (6) (5) any purpose announced or described by the seller that is in
78	78	31 violation of this chapter;
79	79	32 commits a Class A infraction for dealing in paraphernalia.
80	80	33 (b) A person who knowingly or intentionally violates subsection (a)
81	81	34 commits a Class A misdemeanor. However, the offense is a Level 6
82	82	35 felony if the person has a prior unrelated judgment or conviction under
83	83	36 this section.
84	84	37 (c) This section does not apply to the following:
85	85	38 (1) Items marketed for use in the preparation, compounding,
86	86	39 packaging, labeling, or other use of marijuana, hash oil, hashish,
87	87	40 salvia, a synthetic drug, or a controlled substance as an incident
88	88	41 to lawful research, teaching, or chemical analysis and not for sale.
89	89	42 (2) Items marketed for or historically and customarily used in
90	90	2025 IN 114—LS 6555/DI 151 3
91	91	1 connection with the planting, propagating, cultivating, growing,
92	92	2 harvesting, manufacturing, compounding, converting, producing,
93	93	3 processing, preparing, testing, analyzing, packaging, repackaging,
94	94	4 storing, containing, concealing, injecting, ingesting, or inhaling
95	95	5 of tobacco or any other lawful substance.
96	96	6 (3) A qualified entity (as defined in IC 16-41-7.5-3) that provides
97	97	7 a syringe or needle as part of a program under IC 16-41-7.5.
98	98	8 (4) Any entity or person that provides funding to a qualified entity
99	99	9 (as defined in IC 16-41-7.5-3) to operate a program described in
100	100	10 IC 16-41-7.5.
101	101	2025 IN 114—LS 6555/DI 151